PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Dec-2025 IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform Businesswire
02-Dec-2025 Tenpoint Therapeutics, Ltd. to Participate in Upcoming Investor Conference Businesswire
02-Dec-2025 Aera Therapeutics to Present Preclinical Data on AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases, at the 67th American Society of Hematology (ASH) Annual Meeting Businesswire
02-Dec-2025 Strand Therapeutics Appoints Jeb Keiper to Board of Directors Businesswire
02-Dec-2025 QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting Businesswire
02-Dec-2025 enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness Businesswire
02-Dec-2025 ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions Businesswire
02-Dec-2025 Valo Health Appoints Rita Kale as Chief Financial Officer Businesswire
02-Dec-2025 Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis Businesswire
02-Dec-2025 Imvax Announces Positive Top-line Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM Businesswire
02-Dec-2025 Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance Businesswire
02-Dec-2025 tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH tiakis Biotech AG
02-Dec-2025 GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases Newswire
02-Dec-2025 Bayer Welcomes Solicitor General Support for U.S. Supreme Court Review Businesswire
02-Dec-2025 With 40% of Agentic AI Projects Predicted to Fail, Leading Software Developer Says Compliance Is the One Place Where Agentic AI Will Thrive Businesswire
02-Dec-2025 Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions Businesswire
02-Dec-2025 Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results Businesswire
01-Dec-2025 Human Vaccines Strategic Business Analysis Report 2025: Emergence of New Pathogens Drives Demand for Novel Vaccines - Global Forecast to 2030 - ResearchAndMarkets.com Businesswire
01-Dec-2025 AltPep Corporation Presents New Preclinical Data at CTAD 2025 Demonstrating SOBIN-AD, its Custom-Designed Peptide for Alzheimer’s Disease, Improves Behavior in Both Symptomatic and Asymptomatic Disease Businesswire
01-Dec-2025 Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025 Businesswire